The current valuation score of CG Oncology Inc is 9.05, ranking 63 out of 388 in the Biotechnology & Medical Research industry. Its current P/E ratio is -29.33, which is -66.92% below the recent high of -9.70 and -53.00% above the recent low of -44.88.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.